Alprenoxime

From WikiMD's WELLNESSPEDIA

Alprenoxime.png

Alprenoxime is a chemical compound that is classified as a beta blocker. It is a derivative of alprenolol, which is used in the treatment of hypertension and angina pectoris. Alprenoxime is known for its potential pharmacological effects, although it is not as widely studied or used as other beta blockers.

Chemical Structure and Properties[edit]

Alprenoxime is an oxime derivative of alprenolol. The chemical structure of alprenoxime includes a phenyl ring, a secondary alcohol group, and an oxime functional group. The presence of the oxime group differentiates it from its parent compound, alprenolol.

Pharmacology[edit]

As a beta blocker, alprenoxime works by blocking the beta-adrenergic receptors in the heart and blood vessels. This action leads to a decrease in heart rate and blood pressure, making it useful in the management of cardiovascular conditions. However, the specific pharmacokinetics and pharmacodynamics of alprenoxime are not well-documented in the literature.

Medical Uses[edit]

While alprenoxime is related to alprenolol, it is not commonly used in clinical practice. Alprenolol itself is used to treat conditions such as hypertension, angina, and certain types of arrhythmias. The potential medical uses of alprenoxime would likely be similar, but further research is needed to confirm its efficacy and safety.

Side Effects[edit]

The side effects of alprenoxime are not well-documented, but they would be expected to be similar to those of other beta blockers. Common side effects of beta blockers include bradycardia, hypotension, fatigue, and dizziness. More serious side effects can include bronchospasm and heart failure in susceptible individuals.

Research and Development[edit]

Research on alprenoxime is limited, and it is not a widely studied compound. Most of the available information is derived from its relationship to alprenolol. Further studies are needed to fully understand its pharmacological profile and potential therapeutic uses.

See Also[edit]

References[edit]


External Links[edit]

-

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Alprenoxime&oldid=5808313"